Global Health Gateway
Welcome to BioMed Central's Global Health Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.
Presents results of the field evaluation of a LAMP assay for malaria diagnosis that had been previously evaluated in a centralized laboratory with previously collected and stored samples. LAMP detected a higher proportion of low density malaria infections than the other methods tested and may be used for large campaigns of systematic screening and treatment.
Evaluates the effectiveness of a training programme for improving the diagnostic and treatment quality of paediatric malaria, as provided by community health workers in rural communities, in situations where there are no other care options.
This study shows all the remaining difficulties to identify, diagnose and treat malaria cases in institutions of health in Haiti. With a good methodology, it analyses accurately the sources and causes of these difficulties, both material difficulties (lack of equipment or lack of RDTs) and of human origin (lack of rigor in managing of patients, deficiencies in communication between clinicians in charge of patients and technicians in charge of diagnosis, insufficient levels of knowledge). There is still long way to go, in Haiti, to address and remedy these shortcomings.
Vivax malaria is an important public health issue in the Amazon region, and migration across the border between Brazil and French Guiana contributes to the maintenance of the disease. This study evaluates the therapeutic and parasitological responses of patients with vivax malaria treated with chloroquine and primaquine in the socio-environmental context of cross-border interactions.
Presents a cohort study examining the long-term impact of malaria on school performance among children on the Thai-Myanmar border.
Describes a PK interaction study with relevant combinations of drugs that have not been investigated thoroughly together previously. Such data are important for the management of drug interactions in co-infected HIV-malaria patients.
The findings show how the AMFm programme contributed to making quality anti-malarials more available in remote areas in Kenya and Ghana. Therefore, the AMFm approach can inform other health interventions aiming at reaching hard-to-reach populations, particularly in the context of universal access to health interventions.
This study of a huge amount of parasites genotyped from two Plasmodium species and from different regions of Papua New Guinea, focuses on a few mutations in four genes, pfdhfr, pfdhps, pfcrt and pfmdr1, that have long been studied for their roles in resistances to different drug classes. The LDR-FMA multiplex method presented is a very interesting tool for this type of studies.
BMC Infectious Diseases 2015, 15:337
Virology Journal 2015, 12:159
The Journal of Headache and Pain 2015, 16:86